Iranian Journal of Psychiatry and Behavioral Sciences

Published by: Kowsar

Non-Compliance and Related Factors in Patients With Bipolar I Disorder: A Six Month Follow-Up Study

Sanaz Azadforouz 1 , Amir Shabani 2 , * , Shabnam Nohesara 2 and Masoud Ahmadzad-Asl 2
Authors Information
1 Babol University of Medical Sciences, Babol, IR Iran
2 Tehran Psychiatric Institute, Mental Health Research Centre, Iran University of Medical Sciences, Teharn, IR Iran
Article information
  • Iranian Journal of Psychiatry and Behavioral Sciences: June 30, 2016, 10 (2); e2448
  • Published Online: March 15, 2016
  • Article Type: Original Article
  • Received: October 7, 2014
  • Revised: February 10, 2015
  • Accepted: July 4, 2015
  • DOI: 10.17795/ijpbs-2448

To Cite: Azadforouz S, Shabani A, Nohesara S, Ahmadzad-Asl M. Non-Compliance and Related Factors in Patients With Bipolar I Disorder: A Six Month Follow-Up Study, Iran J Psychiatry Behav Sci. 2016 ; 10(2):e2448. doi: 10.17795/ijpbs-2448.

Abstract
Copyright © 2016, Mazandaran University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Montoya A, Perez Sanchez Toledo J, Gilaberte I, Gonzalez-Pinto A, Haro JM, Vieta E, et al. Patterns of drug treatment for manic episode in the clinical practice. Outcomes of the Spanish sample in the EMBLEM Study. Actas Esp Psiquiatr. 2007; 35(5): 315-22[PubMed]
  • 2. Lingam R, Scott J. Treatment non-adherence in affective disorders. Acta Psychiatr Scand. 2002; 105(3): 164-72[PubMed]
  • 3. Colom F, Vieta E, Martinez-Aran A, Reinares M, Benabarre A, Gasto C. Clinical factors associated with treatment noncompliance in euthymic bipolar patients. J Clin Psychiatry. 2000; 61(8): 549-55[PubMed]
  • 4. Connelly CE. Compliance with outpatient lithium therapy. Perspect Psychiatr Care. 1984; 22(2): 44-50
  • 5. Keck PJ, McElroy SL, Strakowski SM, Bourne ML, West SA. Compliance with maintenance treatment in bipolar disorder. Psychopharmacol Bull. 1997; 33(1): 87-91[PubMed]
  • 6. Licht RW, Vestergaard P, Rasmussen NA, Jepsen K, Brodersen A, Hansen PE. A lithium clinic for bipolar patients: 2-year outcome of the first 148 patients. Acta Psychiatr Scand. 2001; 104(5): 387-90[PubMed]
  • 7. Perlick DA, Rosenheck RA, Kaczynski R, Kozma L. Medication non-adherence in bipolar disorder: a patient-centered review of research findings. Clin Approaches Bipolar Disord. 2004; 3(2): 56-64
  • 8. Guscott R, Taylor L. Lithium prophylaxis in recurrent affective illness. Efficacy, effectiveness and efficiency. Br J Psychiatry. 1994; 164(6): 741-6[PubMed]
  • 9. Colom F, Vieta E. Treatment adherence in bipolar patients. Clin Approaches Bipolar Disord. 2002; 1: 49-56
  • 10. Suppes T, Baldessarini RJ, Faedda GL, Tohen M. Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Arch Gen Psychiatry. 1991; 48(12): 1082-8[PubMed]
  • 11. Gonzalez-Pinto A, Mosquera F, Alonso M, Lopez P, Ramirez F, Vieta E, et al. Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment. Bipolar Disord. 2006; 8(5 Pt 2): 618-24[DOI][PubMed]
  • 12. Kulhara P, Basu D, Mattoo SK, Sharan P, Chopra R. Lithium prophylaxis of recurrent bipolar affective disorder: long-term outcome and its psychosocial correlates. J Affect Disord. 1999; 54(1-2): 87-96[PubMed]
  • 13. Robinson D, Woerner MG, Alvir JM, Bilder R, Goldman R, Geisler S, et al. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry. 1999; 56(3): 241-7[PubMed]
  • 14. Caton CLM, Koh SP, Fleiss JL, Barrow S, Goldstein JM. Rehospitalization in Chronic Schizophrenia. J Nervous Ment Dis. 1985; 173(3): 139-48[DOI]
  • 15. Svarstad BL, Shireman TI, Sweeney JK. Using drug claims data to assess the relationship of medication adherence with hospitalization and costs. Psychiatr Serv. 2001; 52(6): 805-11[DOI][PubMed]
  • 16. Muller-Oerlinghausen B, Wolf T, Ahrens B, Glaenz T, Schou M, Grof E, et al. Mortality of patients who dropped out from regular lithium prophylaxis: a collaborative study by the International Group for the Study of Lithium-treated patients (IGSLI). Acta Psychiatr Scand. 1996; 94(5): 344-7[PubMed]
  • 17. Muller-Oerlinghausen B. Arguments for the specificity of the antisuicidal effect of lithium. Eur Arch Psychiatry Clin Neurosci. 2001; 251 Suppl 2-5[PubMed]
  • 18. Yerevanian BI, Koek RJ, Mintz J. Bipolar pharmacotherapy and suicidal behavior. Part I: Lithium, divalproex and carbamazepine. J Affect Disord. 2007; 103(1-3): 5-11[DOI][PubMed]
  • 19. Clatworthy J, Bowskill R, Rank T, Parham R, Horne R. Adherence to medication in bipolar disorder: a qualitative study exploring the role of patients' beliefs about the condition and its treatment. Bipolar Disord. 2007; 9(6): 656-64[DOI][PubMed]
  • 20. Jamison KR, Gerner RH, Goodwin FK. Patient and physician attitudes toward lithium: relationship to compliance. Arch Gen Psychiatry. 1979; 36(8 Spec No): 866-9[PubMed]
  • 21. Miklowitz DJ. Longitudinal outcome and medication noncompliance among manic patients with and without mood-incongruent psychotic features. J Nerv Ment Dis. 1992; 180(11): 703-11[PubMed]
  • 22. Maarbjerg K, Aagaard J, Vestergaard P. Adherence to lithium prophylaxis: I. Clinical predictors and patient's reasons for nonadherence. Pharmacopsychiatry. 1988; 21(3): 121-5[DOI][PubMed]
  • 23. Comtois KA, Ries R, Armstrong HE. Case manager ratings of the clinical status of dually diagnosed outpatients. Hosp Community Psychiatry. 1994; 45(6): 568-73[PubMed]
  • 24. Weiss RD, Greenfield SF, Najavits LM, Soto JA, Wyner D, Tohen M, et al. Medication compliance among patients with bipolar disorder and substance use disorder. J Clin Psychiatry. 1998; 59(4): 172-4[PubMed]
  • 25. Salloum IM, Thase ME. Impact of substance abuse on the course and treatment of bipolar disorder. Bipolar Disord. 2000; 2(3 Pt 2): 269-80[PubMed]
  • 26. Sajatovic M, Ignacio RV, West JA, Cassidy KA, Safavi R, Kilbourne AM, et al. Predictors of nonadherence among individuals with bipolar disorder receiving treatment in a community mental health clinic. Compr Psychiatry. 2009; 50(2): 100-7[DOI][PubMed]
  • 27. Ghaemi SN, Rosenquist KJ, Ko JY, Baldassano CF, Kontos NJ, Baldessarini RJ. Antidepressant treatment in bipolar versus unipolar depression. Am J Psychiatry. 2004; 161(1): 163-5[DOI][PubMed]
  • 28. Peralta V, Cuesta MJ. Lack of insight in mood disorders. J Affect Disord. 1998; 49(1): 55-8[DOI]
  • 29. Yen CF, Chen CS, Ko CH, Yeh ML, Yang SJ, Yen JY, et al. Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: prospective study. Psychiatry Clin Neurosci. 2005; 59(4): 403-9[DOI][PubMed]
  • 30. Berk M, Berk L, Castle D. A collaborative approach to the treatment alliance in bipolar disorder. Bipolar Disord. 2004; 6(6): 504-18[DOI][PubMed]
  • 31. Keck PJ, McElroy SL, Strakowski SM, West SA, Sax KW, Hawkins JM, et al. 12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode. Am J Psychiatry. 1998; 155(5): 646-52[DOI][PubMed]
  • 32. Sajatovic M, Valenstein M, Blow FC, Ganoczy D, Ignacio RV. Treatment adherence with antipsychotic medications in bipolar disorder. Bipolar Disord. 2006; 8(3): 232-41[DOI][PubMed]
  • 33. Frank E, Prien RF, Kupfer DJ, Alberts L. Implications of noncompliance on research in affective disorders. Psychopharm Bull. 1985; 21(1): 37
  • 34. Goodwin FK, Jamison KR. Manic-depressive illness: bipolar disorders and recurrent depression. 2007;
  • 35. Danion JM, Neunreuther C, Krieger-Finance F, Imbs JL, Singer L. Compliance with long-term lithium treatment in major affective disorders. Pharmacopsychiatry. 1987; 20(5): 230-1[DOI][PubMed]
  • 36. Frank E, Prien RF, Kupfer DJ, Alberts L. Implications of noncompliance on research in affective disorders. Psychopharmacol Bull. 1985; 21(1): 37-42[PubMed]
  • 37. Aagaard J, Vestergaard P, Maarbjerg K. Adherence to lithium prophylaxis: II. Multivariate analysis of clinical, social, and psychosocial predictors of nonadherence. Pharmacopsychiatry. 1988; 21(4): 166-70[DOI][PubMed]
  • 38. Scott J, Pope M. Nonadherence with mood stabilizers: prevalence and predictors. J Clin Psychiatry. 2002; 63(5): 384-90[PubMed]
  • 39. Shabani A, Taheri A, Azadforouz S, Abbasi CN, Mousavi Z, Zangeneh K, et al. Bipolar Disorder Patients Follow-up (BDPF): methods and materials. J Res Med Sci. 2010; 15(4): 229-34[PubMed]
  • 40. Diagnostic and statiscal manual of mental disorder 2000;
  • 41. First MD, Spitzer RL, Gilbbon M, Williams JBW. Structured clinical interview for DSM-IV axis I disorders (SCID-I), clinical version (Administration booklet) 1997;
  • 42. Gibbon M, Spitzer RL, Williams JBW, Benjamin LS, First MB. User,s guide for the structured clinical interview for DSM-IV Axis II personality disorders (SCID-II) 1997;
  • 43. Sharifi V, Assadi SM, Mohammadi MR, Amini H, Kaviani H, Semnani Y, et al. A Persian translation of the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition: psychometric properties. Compr Psychiatry. 2009; 50(1): 86-91[DOI][PubMed]
  • 44. McIntyre R, Kennedy S, Bagby RM, Bakish D. Assessing full remission. J Psychiatry Neurosci. 2002; 27(4): 235-9[PubMed]
  • 45. Kobak KA, Greist JH, Jefferson JW, Katzelnick DJ. Computer-administered clinical rating scales. A review. Psychopharmacology (Berl). 1996; 127(4): 291-301[PubMed]
  • 46. Amini H, Sharifi V, Nejatisafa A, Arbabi M, Tabatabaie M, Alimadadi Z, et al. One year follow-up of patients with bipolar disorder admitted to Roozbeh Hospital. Iran J Psychiatr Clin Psychol. 2009; 15(2): 168-74
  • 47. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatr. 1978; 133(5): 429-35[DOI]
  • 48. Barekatain M, Tavakoli M, Molavi H, Maroufi M, Salehi M. Standardization, reliability and validity of the Young Mania Rating Scale. Psychology. 2007; 11(2): 150-66
  • 49. Andreasen NC. The scale for the assessment of positive symptoms (SAPS). 1984;
  • 50. Bell V, Halligan PW, Ellis HD. Diagnosing delusions: a review of inter-rater reliability. Schizophr Res. 2006; 86(1-3): 76-9[DOI][PubMed]
  • 51. Alaghband-Rad J, Boroumand M, Amini H, Sharifi V, Omid A, Davari-Ashtiani R, et al. Non-affective Acute Remitting Psychosis: a preliminary report from Iran. Acta Psychiatr Scand. 2006; 113(2): 96-101[DOI][PubMed]
  • 52. Hogan TP, Awad AG, Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med. 1983; 13(1): 177-83[PubMed]
  • 53. Gilmer TP, Dolder CR, Lacro JP, Folsom DP, Lindamer L, Garcia P, et al. Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. Am J Psychiatry. 2004; 161(4): 692-9[DOI][PubMed]
  • 54. Valenstein M, Blow FC, Copeland LA, McCarthy JF, Zeber JE, Gillon L, et al. Poor antipsychotic adherence among patients with schizophrenia: medication and patient factors. Schizophr Bull. 2004; 30(2): 255-64[PubMed]
  • 55. Valenstein M, Copeland LA, Blow FC, McCarthy JF, Zeber JE, Gillon L, et al. Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Med Care. 2002; 40(8): 630-9[DOI][PubMed]
  • 56. Sharifi A, Shabani A, Ahmadzad-Asl M. The pattern of adherence in patients with bipolar I disorder; an eight weeks study. Iran J Psychiatr Behav Sci. 2009; 3(2): 39-43
  • 57. Sajatovic M, Bauer MS, Kilbourne AM, Vertrees JE, Williford W. Self-reported medication treatment adherence among veterans with bipolar disorder. Psychiatr Serv. 2014;
  • 58. Sajatovic M, Biswas K, Kilbourne AK, Fenn H, Williford W, Bauer MS. Factors associated with prospective long-term treatment adherence among individuals with bipolar disorder. Psychiatr Serv. 2008; 59(7): 753-9[DOI][PubMed]
  • 59. Zeber JE, Copeland LA, Good CB, Fine MJ, Bauer MS, Kilbourne AM. Therapeutic alliance perceptions and medication adherence in patients with bipolar disorder. J Affect Disord. 2008; 107(1-3): 53-62[DOI][PubMed]
  • 60. Baldessarini R, Henk H, Sklar A, Chang J, Leahy L. Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence. Psychiatr Serv. 2008; 59(10): 1175-83[DOI][PubMed]
  • 61. Shabani A, Eftekhar M. Non Complication after first episode of mania or mix mod stabilizer : A 17 month follow up. Iranian J Psychiatr Behav Sci. 2007; 1(2)
  • 62. Sajatovic M. predictors of non adherence among individual with BP receiving treatment in common mental health clinic. Psychiatry. 2009; 5: 100-7
  • 63. Lingam R, Scott J. Treatment non‐adherence in affective disorders. Acta Psychiatrica Scandinavica. 2002; 105(3): 164-72
  • 64. Ghorayshizadeh MA, Kouchaksaraei F, Pezeshki M. Evaluation of Risk Factors of Relapse in Bipolar I Disorders and Its Relation to Demographic Feature. Med J Tabriz unit Med Sci. 2009; 31(2): 77-81
  • 65. Rosa AR, Marco M, Fachel JM, Kapczinski F, Stein AT, Barros HM. Correlation between drug treatment adherence and lithium treatment attitudes and knowledge by bipolar patients. Prog Neuropsychopharmacol Biol Psychiatry. 2007; 31(1): 217-24[DOI][PubMed]
  • 66. Colom F, Vieta E, Tacchi MJ, Sanchez-Moreno J, Scott J. Identifying and improving non-adherence in bipolar disorders. Bipolar Disord. 2005; 7 Suppl 5: 24-31[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments